Prevention‎ > ‎Treat the Bite!‎ > ‎

2016 Swiss Treatment Guidelines

NOT RECOMMENDED

The 2016 Lyme Treatment Guidelines written by infectious disease doctors in Switzerland are abominable. This is a sneak preview into our futures- soon to be determined by the upcoming IDSA/CDC guidelines in the USA.

Summarized, the abstract says- no such thing as chronic Lyme and no treatment should be provided for Post Treatment Lyme Disease Syndrome.

Links to the abstract and study, along with some quotes, are shared below.

NOT RECOMMENDED

Abstract Here
https://www.ncbi.nlm.nih.gov/pubmed/27922168

Full Guidelines Here


Attempt To Discredit Lyme Treating Doctors-  "Last but not least, misconceptions of some healthcare professionals contribute to iatropathogenesis of “chronic” Lyme borreliosis, by supporting unscientific views – often with substantial financial interests – about Lyme disease [86]."

Quote-  “Growing and unequivocal evidence confirms that prolonged or repeated antibiotic therapy for PTLDS is not beneficial, but potentially harmful and therefore contraindicated." 

Quote on Treatment-  "The main therapeutic options remain cognitive behavioural therapy and low-impact aerobic exercise programmes.

Treatment To Be Offered-   "A corresponding concept, ExPRESS (E stands for exercise; P stands for psychiatric comorbidity; R stands for regaining function with emphasis on realistic goals and regular activity; E stands for education; S for sleep; and the final S for stress and the need to manage and reduce it), has been introduced by Hassett and Gevirtz for the treatment of fibromyalgia, but might also be a promising approach for the treatment of PTLDS [94]."

Effort Of The Authors To Do Their Research- "We found no further data, particularly no prospective controlled studies on Lyme borreliosis, which may change these decade-old case definitions.  For the diagnosis of PTLDS, a set of fact-based diagnostic criteria has to be fulfilled. 

Importantly, positive Lyme serology without previous defined clinical manifestations of Lyme borreliosis does not qualify for the diagnosis of PTLDS, given the high prevalence of asymptomatic seropositivity in populations living in endemic areas."

NOT RECOMMENDED

NOT RECOMMENDED

NOT RECOMMENDED













































































click tracking